Master degree in Pharmacology / Clinical Pharmacology / Pharmacy Practice / Clinical Research. OR Pharm.D/ MBBS/BDS from a recognized university / institute.
M.Sc./M.Pharm/M.S. in Chemistry / Analytical Chemistry / Pharmaceutical Chemistry/ Pharmacognosy / Natural Products Chemistry/ Biotechnology from a recognized university or equivalent.
A first Class B.Pharmacy degree with a Masters degree (M.Pharm) in appropriate branch of specialization in Pharmacy. A PCI recognized Pharm.D degree holder shall also be eligible for the posts of Assistant Professor in the subjects of pathophysiology, pharmacology and pharmacy practice.
Doctoral Degree in Science from a recognized University or equivalent : Extensive experience in organic synthesis of small molecules for medicinal chemistry.
Maintain robust governance for label changes triggered by safety signals, clinical/CMC updates, and regulatory intelligence; ensure harmonized global implementation timelines and traceability.
MedPlus One of the most trusted gateways to medicines and general provision With an aim to eradicate fake and ineffective medicines, and supply high-quality medicines in India, MedPlus was launched in 2006 in Hyderabad.
Bachelors in life science/healthcare required; Advanced degree or equivalent education / degree in life sciences / healthcare preferred (PhD/MD/PharmD/ Masters).
Looking for a Clinical Data Management Professional who thrives in a dynamic, international environment and brings a strong commitment to data quality and regulatory compliance.
Applications are invited for engagement of JRF under the GSBTM funded project entitled Investigating the therapeutic synergism of stem cell therapy and GHRH receptor analogue in post- stroke neuronal regeneration and management of vasogenic edema in the Department of Pharmacology and Toxicology, NIPER-Ahmedabad.
Preparation and updation of SOPs, BMRs, Log books, protocols and compliance thereof with training of people on the same.
Handling and monitoring of Environmental monitoring systemsystem.
This is a high-impact leadership opportunity to shape and drive enterprise-wide project governance across R&D and Manufacturing. Strong exposure to R&D, Drug Substance & Drug Product Manufacturing projects in Biologies Proven expertise in Program / Portfolio Management.
Support initiatives to maintain or improve quality performance and compliance of operational activities including risk management, health authority reporting, IT systems
The U.S. Department of Commerce has launched a new application process that could allow pharmaceutical companies to significantly reduce looming Section 232 tariffs if they commit to moving drug manufacturing operations to the United States.
Japanese drugmaker Eisai is projecting strong commercial growth for its Alzheimers therapy Leqembi, signaling growing confidence in the global adoption of disease-modifying treatments for early Alzheimer’s disease.